Loading clinical trials...
Loading clinical trials...
The aim of this study is to prospectively determine the incidence of brain metastases in metastatic colorectal cancer patients using systematic annual screening by MRI.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Poitiers University Hospital
NCT03803553 · Metastatic Colon Cancer, Stage III Colon Cancer
NCT07321106 · Colorectal Cancer, Colorectal Cancer (CRC), and more
NCT05714124 · Hepatocellular Carcinoma, Cholangiocarcinoma, and more
NCT06929338 · Metastatic Colon Adenocarcinoma, Metastatic Colon Cancer, and more
NCT03730558 · Metastatic Colon Cancer
C.H.U. d'Amiens
Amiens
Hôpital Privé Jean Mermoz
Lyon
C.H.U. de Poitiers
Poitiers
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions